Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DISHMAN PHARMA ALKEM LABORATORIES/
DISHMAN PHARMA
 
P/E (TTM) x 37.5 30.0 125.1% View Chart
P/BV x 6.5 3.3 195.1% View Chart
Dividend Yield % 1.0 0.7 152.3%  

Financials

 ALKEM LABORATORIES   DISHMAN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
DISHMAN PHARMA
Mar-16
ALKEM LABORATORIES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,625374 968.3%   
Low Rs2,835129 2,199.4%   
Sales per share (Unadj.) Rs970.1197.0 492.4%  
Earnings per share (Unadj.) Rs84.221.2 397.4%  
Cash flow per share (Unadj.) Rs110.234.7 317.4%  
Dividends per share (Unadj.) Rs50.002.00 2,500.0%  
Avg Dividend yield %1.50.8 194.8%  
Book value per share (Unadj.) Rs756.4179.9 420.5%  
Shares outstanding (eoy) m119.5780.70 148.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.31.3 260.7%   
Avg P/E ratio x38.411.9 323.0%  
P/CF ratio (eoy) x29.37.3 404.3%  
Price / Book Value ratio x4.31.4 305.2%  
Dividend payout %59.49.4 629.1%   
Avg Mkt Cap Rs m386,20720,307 1,901.8%   
No. of employees `000NANA-   
Total wages/salary Rs m21,3145,355 398.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99315,898 729.6%  
Other income Rs m2,161265 814.2%   
Total revenues Rs m118,15316,163 731.0%   
Gross profit Rs m15,0654,103 367.1%  
Depreciation Rs m3,1041,091 284.6%   
Interest Rs m1,074944 113.7%   
Profit before tax Rs m13,0482,334 559.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,980624 477.8%   
Profit after tax Rs m10,0681,710 588.8%  
Gross profit margin %13.025.8 50.3%  
Effective tax rate %22.826.7 85.5%   
Net profit margin %8.710.8 80.7%  
BALANCE SHEET DATA
Current assets Rs m86,06411,018 781.1%   
Current liabilities Rs m37,0719,517 389.5%   
Net working cap to sales %42.29.4 447.4%  
Current ratio x2.31.2 200.5%  
Inventory Days Days3357 57.2%  
Debtors Days Days673 1,918.4%  
Net fixed assets Rs m37,24518,787 198.2%   
Share capital Rs m239161 148.1%   
"Free" reserves Rs m90,20814,354 628.4%   
Net worth Rs m90,44714,516 623.1%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m124,54129,805 417.8%  
Interest coverage x13.23.5 378.9%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.90.5 174.6%   
Return on assets %8.98.9 100.5%  
Return on equity %11.111.8 94.5%  
Return on capital %15.617.5 89.1%  
Exports to sales %14.624.9 58.6%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs m16,9163,956 427.6%   
Imports (cif) Rs mNA594 0.0%   
Fx inflow Rs m16,9164,952 341.6%   
Fx outflow Rs m4,190697 601.3%   
Net fx Rs m12,7274,255 299.1%   
CASH FLOW
From Operations Rs m16,8252,786 603.8%  
From Investments Rs m1,128-1,529 -73.8%  
From Financial Activity Rs m-17,608-941 1,871.2%  
Net Cashflow Rs m416317 131.5%  

Share Holding

Indian Promoters % 56.7 61.4 92.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 23.0 106.3%  
FIIs % 8.5 12.0 70.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 38.6 112.1%  
Shareholders   65,184 52,291 124.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Dishman Pharma Share Price Performance

Period ALKEM LABORATORIES Dishman Pharma S&P BSE HEALTHCARE
1-Day -1.18% 2.87% 1.18%
1-Month -0.99% -2.45% -0.75%
1-Year 52.26% 96.38% 61.82%
3-Year CAGR 21.70% 89.34% 18.16%
5-Year CAGR 22.99% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.